The Dutch association for Nuclear Health (NVNG) held a symposium in honor of their 50th anniversary. Managing director Hermen van der Lugt gave a presentation on behalf of PALLAS.
During the presentation and the panel discussion afterwards the progress PALLAS is making was discussed. Bas van den Dungen (DG at Curatieve Zorg, VWS) also stated the importance of the realization of PALLAS.
Other presentators talked about e.g. developments on therapy with medical isotopes, such as PRRT (Peptide Receptor Radionuclide Therapy), where Lutetium-177-Octreotate is being used.
The entire program is available here.